Showing results (901-910 of 1,024) with videos related to

Sort By:
Pageof 103
The Lancet. Oncology|February 10, 2009
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II studyEzra E W Cohen, Darren W Davis, Theodore G Karrison, et al.
Practical Radiation Oncology|April 22, 2017
Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice GuidelineDavid J Sher, David J Adelstein, Gopal K Bajaj, et al.
Respiratory Medicine|April 19, 2026
Long-term Safety of the Pfizer-BioNTech COVID-19 Vaccine: Results from the HERO-Together StudyEmily C O'Brien, Cherise Wong, Jesse M DeLaRosa, et al.
Archives of Neurology|February 14, 2007
Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventionsOlaf Stüve, Christina M Marra, Petra D Cravens, et al.
Cancer|October 25, 2011
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic diseaseJoseph K Salama, Michael D Hasselle, Steven J Chmura, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 27, 2007
Spatial inhomogeneity of common carotid artery intima-media is increased in dialysis patientsMarc M H Hermans, Jeroen P Kooman, Vincent Brandenburg, et al.
Immunologic Research|November 15, 2014
Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein IA Artenjak, I Locatelli, H Brelih, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinomaM Schlumberger, R Elisei, S Müller, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck CancerTanguy Y Seiwert, James M Melotek, Elizabeth A Blair, et al.
Biomaterials|April 19, 2020
Redirecting extracellular proteases to molecularly guide radiosensitizing drugs to tumorsDina V Hingorani, Jessica L Crisp, Matthew K Doan, et al.
Pageof 103